Lupus erythematosus is an autoimmune inflammatory connective tissue disease. From the perspective of pathogenesis, the mainstream view is that genetic factors, environmental factors, estrogen levels and other factors interact to cause excessive proliferation of B cells in patients, resulting in a large number of autoantibodies. The antibody binds to… Continue Reading The first new drug for lupus erythematosus, Belimumab was approved for listing in China
Vitamins and trace elements play an important role in the development of type 2 diabetes and its complications. Among the many vitamins and trace elements, some are beneficial to diabetic patients, some are harmful to diabetic patients, and you can’t make up for it! I. Which vitamins are… Continue Reading Which vitamins and trace elements are beneficial for patients with type 2 diabetes?
The prototype of the best-selling book “The Billion-Dollar Molecule” in the pharmaceutical industry is Vertex. The company, which was founded in 1989, started with $10 million in funds and can be said to be a dark horse enterprise in the pharmaceutical industry. Vertex has created three drugs with annual… Continue Reading “The Billion-Dollar Molecule” prototype Vertex’s “Next City”
Opioids are usually the mainstay of perioperative and chronic pain, and even local pain treatment, but these drugs have many side effects, including nausea, irritations, itching, urinary retention, constipation, etc., and more serious tolerance. , addiction and the risk of overuse of death. Opioids are usually administered systemically, primarily… Continue Reading Tetrodotoxin is “tamed” and has a local analgesic effect for up to 3 days! Or an alternative to opioids
Strictly speaking, as long as you take the medicine, you are no longer suitable for drinking. Whether it is red wine beer or white wine. Not only cephalosporins, but also a few major types of drugs are particularly deadly to alcohol. Taking these drugs and drinking them will lead… Continue Reading Do not drink alcohol after taking these 7 drugs, there is a risk of death
Recently, the US FDA approved Novartis’s spinal muscular atrophy (SMA) gene therapy Zolgensma, which brought dawn to SMA patients and their families, but it has once again refreshed the drug price record with a price of 2.1 million US dollars, making it the most expensive medicine in history. The… Continue Reading World Health Assembly passed the “Transparent Drug Market” resolution: will affect future drug pricing
Some people say that amlodipine has a protective effect on the heart, and left-handedness is only a blood pressure reduction. Is it really? I. Levamlodipine Amlodipine, a third-generation long-acting calcium antagonist, is a commonly used drug for the treatment of hypertension and angina pectoris. The half-life is as… Continue Reading Amlodipine protects the heart, and levoamlodipine can only reduce blood pressure?
The regulation of human blood glucose concentration is mainly achieved by the mutual restriction of insulin and glucagon at multiple levels. Among them, insulin produced by islet β cells is responsible for promoting blood glucose absorption and lowering blood glucose concentration. Islet beta cell destruction or dysfunction can lead… Continue Reading Nature’s paper: Treating diabetes with cell therapy is worth looking forward to
Pancreatic cancer is one of the most malignant tumors. It is called “the king of cancer” because of its low survival rate and extremely short survival period. It is usually asymptomatic in the early stage and often spreads to the whole body when it is diagnosed. Pancreatic cancer is… Continue Reading Nature: The king of cancer also has weakness
Metformin is the most widely used type 2 diabetes drug, and is known as a “magic medicine” because of its anti-cancer and anti-aging effects. Now, scientists from the University of Dundee in the UK have recently discovered that metformin can also reverse the thickening of harmful myocardial walls that… Continue Reading Metformin may reduce the risk of heart disease, the first clinical trial results in top journals